LISTA SUBSTANCIAS POR CATEGORIA DE DOPING Y METODOS LIST OF CATEGORIES OF DOPING SUBSTANCES AND METHODS Adopted by the UCI President on the proposal of the Antidoping Commission of the UCI. Entry into effect: 1st May 1999 List Nr.01/99 I. CATEGORIES OF DOPING SUBSTANCES
Examples:
* - For caffeine, a sample shall be considered as positive if the concentration in the urine exceeds 12 micrograms/ml. ** - For ephedrine, cathine (norpseudoephedrine) and methylephedrine, a sample shall be considered as positive if the concentration in the urine exceeds 5 micrograms/ml. *** - For pseudoephedrine and phenylpropanolamine, a sample shall be considered as positive if the concentration in the urine exceeds 10 micrograms/ml. Beta 2 agonists The use of aerosols containing the following beta 2 agonists only is permitted: Examples:
Examples:
* For morphine a sample shall be deemed positive if the concentration in the urine exceeds 1 microgramme/ml. Examples:
** For dihydrotestosterone a sample will be considered positive if the concentrations of dihydrotestosterone and its metabolites and/or their ratio of non-5alpha steroids exceed the normal level of a human being in such a way that they cannot be attributed to endogenous production. *** As for nandrolone and its derivatives, a sample will be considered positive if the norandrosterone concentration found in the urine after hydrolysis exceeds 5 ng/ml. If the concentration is between 2 and 5 ng/ml or is equal to 5 ng/ml, the Antidoping Commission can request further analyses. If the rider refuses to undergo them, he will be considered positive. **** For analyses other than those performed with a GC/C/IRMS apparatus (see point * above) a sample will be considered positive for testosterone if the level of testosterone/epitestosterone (T/E) is higher than 6. Nevertheless, the rider can request an endocrinological examination to determine if the level is due to a physiological or pathological state. The request for the endocrinological examination must be made to the UCI Antidoping Commission at the latest 5 working days after receipt of the registered letter to the rider's national federation informing it of the positive result, i.e. within the deadline for the request of a counter-analysis (article 64 AER). The Antidoping Commission will decide which laboratory and date will be chosen for the analysis. The cost of the analysis must be paid in advance by the rider. The date of the analysis cannot be postponed. If the results of the endocrinological examination show that that the level of T/E is owing to a physiological or pathological state, the UCI will refund the rider the cost of the examination and issue him with a certificate. In all other cases the cost of the examination is to be paid by the rider. If the rider requests a counter-analysis, he must do so within the deadline stipulated in article 64 of the Antidoping examination regulations, even if he requests an endocrinological examination. If the counter-analysis does not confirm the first analysis, the rider will not be considered positive and the endocrinological examination will not be conducted. Instead of an endocrinological examination the rider can request, within the same deadline, that the Antidoping Commission carries out a retrospective analysis of previous results, which should be addressed to the Commission within 3 working days of the request. If the Antidoping Commission judges that the request is not valid, it may oblige the rider to have an endocrinological examination. If the circumstances are justifiable, the Antidoping Commission may immediately propose a retrospective analysis. The Antidoping Commission may also demand a long term examination consisting of random tests conducted during a period, which it will determine. Examples:
Examples:
Chorionic Gonadotrophin (h.C.G. - Human Chorionic Gonadotrophin): It is well known that the administration of human chorionic gonadotrophin and other related compounds leads to an increase in the production of natural androgenic steroids and is considered equivalent to the exogenous administration of testosterone. A sample would be considered positive if the concentration is above 20 ImU/ml. During the analysis two different immunoassays methods are requested. Corticotrophin (A.C.T.H.): Corticotrophin has been misused to increase the levels of endogenous corticosteroids in the blood, particularly to obtain the mood-elevating effect of corticosteroids. The administration of corticotrophin is regarded as equivalent to the oral, intramuscular or intravenous administration of corticosteroids. (See section III. C) Growth Hormone (h.G.H. Somatotrophin): The use of growth hormone in sport is regarded as amoral and dangerous by reason of its various side-effects such as allergic reactions, diabetogenic effects, and acromegaly when administered in large doses. All release agents of the above-mentioned substances are also prohibited. Erythropoietine (EPO): A glycoproteinic hormone produced in the human kidney which regulates, apparently by retroaction, the rate of synthesis of erythrocytes. Insulin: Permitted only to treat insulin-dependent diabetes. Written notification of insulin-dependent diabetes by an endocrinologist is necessary. Insulin-like Growth Factor (IGF-1). Blood transfusion is the intravenous administration of red blood corpuscles or blood compounds containing red corpuscles. These products may be obtained from blood extracted either from the same individual (auto-transfusion) or from different individuals (hetero-transfusion). The most common indication for the transfusion of red blood corpuscles in current traditional medicine is a large blood loss or severe anaemia. Blood doping is the administration of blood or related substances containing red blood corpuscles to an athlete for reasons other than legitimate medical treatment. This procedure may be preceded by the taking of blood from the athlete, who then goes on with his training in a state of blood insufficiency. These practices contravene the ethics both of sportsmanship and of the medical profession. Moreover, there are risks associated with the transfusion of blood or blood substances. These risks include the development of allergic reactions (skin rashes, fevers, etc.) and also acute haemolytic reactions with kidney damage if an incorrect blood type is used, as well as delayed reactions to transfusion such as fever or jaundice, the transmission of infectious diseases (viral hepatitis and AIDS), the overloading of the circulatory system and metabolic shock. Consequently the practice of blood doping in sport is prohibited. The use of substances and methods which alter the integrity and validity of urine samples used in drug tests is prohibited. Amongst the methods prohibited let us cite catheterisation, the substitution and/or alteration of urine and the inhibition of renal excretion, particularly through probenecide and related compounds, and the administration of epitestosterone. If the concentration of epitestosterone is above 200 ng/ml, laboratories are requested to notify the authorities concerned. The Antidoping Commission recommends in this event that additional checks be carried out. Marijuana is not prohibited, except in the discipline "downhill" in MTB, where a sample will be declared positive as from the detection of more than 40 ng/ml. of THC-COOH (main metabolite of cannabis). The injection of local anaesthetics is permitted on the following conditions to be proved by the rider : Note for:
  |